BIOHAVN PHRMCTCL

 BHVNのチャート


 BHVNの企業情報

symbol BHVN
会社名 Biohaven Pharmaceutical Holding Co Ltd (BIOHAVN PHRMCTCL)
分野(sector)   
産業(industry)   
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 バイオヘイヴン・ファーマスーティカル・ホールディング(Biohaven Pharmaceutical Holding Company Ltd.)は米国のバイオ医薬品会社である。同社はオーファン神経学的徴候と他の神経学的経路を標的とする臨床段階化合物の同定・開発に従事する。同社は複数の後期薬剤候補のポートフォリオを有する。同社のパイプラインはグルタミン酸調節剤の処方物であるBHV-0223、グルタミン酸を調節するニューケミカルエンティティ(NCE)であるBHV-4157、N-メチル-D-アスパラギン酸(NMDA)受容体拮抗作用を標的とする同社の治験代理人であるBHV-5000を含む。臨床化合物であるトリグリルゾールは神経変性疾患と癌の適応症等に適応される。同社のパイプラインにはBHV-3000とBHV-3500を含む。同社はオーファン・神経科学の適応症における他のメカニズム論的アプローチを進めることに焦点を当て、追加の化合物ライセンスを探査する。  バイオヘイブン・ファ―マシュ―ティカル・ホ―ルディングはイギリス領ヴァ―ジン諸島籍の医薬品メ―カ―持株会社。子会社を通じて、希少疾病を含む神経系疾患の治療薬の開発に従事する。主な候補薬には、片頭痛の急性治療薬「Rimegepant」や脊髄小脳失調症の治療を対象とする「Trigriluzole」がある。本社はコネチカット州ニュ―ヘイブン。  Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
本社所在地 c/o Biohaven Pharmaceuticals Inc. 215 Church Street New Haven CT 06510 USA
代表者氏名 Declan Doogan
代表者役職名 Independent Chairman of the Board
電話番号 +1 203-404-0410
設立年月日 41518
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 63人
url www.biohavenpharma.com
nasdaq_url
adr_tso
EBITDA (百万ドル) -224.53700
終値(lastsale)
時価総額(marketcap)
時価総額 (百万ドル) 2221.54300
売上高 (百万ドル) 0.00000
企業価値(EV) (百万ドル) 1957.29400
当期純利益 (百万ドル) -240.92200
決算概要 BRIEF: For the fiscal year ended 31 December 2018 Biohaven Pharmaceutical Holding Co Ltd revenues was not reported. Net loss applicable to common stockholders increased 73% to $240.9M. Higher net loss reflects Research and development - Balancing val increase from $82.5M to $181.6M (expense) General and administrative - Balancing v increase from $11.8M to $26M (expense) Stock-based Compensation in SGA increase of 36% to $8.6M (expense).

 BHVNのテクニカル分析


 BHVNのニュース

   Biohaven Pharmaceutical : 2Q Earnings 2020 | MarketScreener  2020/08/10 13:44:07 MarketScreener
2nd Quarter 2020 Earnings August 10, 2020 Ellie, living with migraine … | August 10, 2020
   Biohaven Pharmaceutical To Report Second Quarter 2020 Financial Results And Recent Business Developments On August 10, 2020  2020/08/05 21:00:00 PR Newswire
NEW HAVEN, Conn., Aug. 5, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, will hold its upcoming…
   Biohaven Pharmaceutical's Migraine Drug To Be Promoted by Khloe Kardashian  2020/07/16 09:45:38 Benzinga
Biohaven Pharmaceutical Holding Co. Ltd.'s (NYSE: BHVN ) "Nurtec ODT" drug will be promoted by media personality Khloe Kardashian, the company announced Wednesday. What Happened Kardashian is joining the New Haven, Connecticut-based company's "Take Back Today" campaign, aimed at promoting the recently-launched orally dissolving tablet for people suffering from migraines. The 36-year old, of the "Keeping Up with the Kardashians" fame, said in a statement that she has been taking the … Full story available on Benzinga.com
   Why Biohaven (BHVN) Might Surprise This Earnings Season  2020/05/04 12:47:00 Zacks Investment Research
Biohaven (BHVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   Biohaven Enters Into Agreement With Genpharm for Distribution of NURTEC™ ODT in the Middle East  2020/04/27 11:30:00 PR Newswire
NEW HAVEN, Conn., April 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT (rimegepant) in the Middle East…
   Biohaven Pharmaceutical : 2Q Earnings 2020 | MarketScreener  2020/08/10 13:44:07 MarketScreener
2nd Quarter 2020 Earnings August 10, 2020 Ellie, living with migraine … | August 10, 2020
   Biohaven Pharmaceutical To Report Second Quarter 2020 Financial Results And Recent Business Developments On August 10, 2020  2020/08/05 21:00:00 PR Newswire
NEW HAVEN, Conn., Aug. 5, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases, will hold its upcoming…
   Biohaven Pharmaceutical's Migraine Drug To Be Promoted by Khloe Kardashian  2020/07/16 09:45:38 Benzinga
Biohaven Pharmaceutical Holding Co. Ltd.'s (NYSE: BHVN ) "Nurtec ODT" drug will be promoted by media personality Khloe Kardashian, the company announced Wednesday. What Happened Kardashian is joining the New Haven, Connecticut-based company's "Take Back Today" campaign, aimed at promoting the recently-launched orally dissolving tablet for people suffering from migraines. The 36-year old, of the "Keeping Up with the Kardashians" fame, said in a statement that she has been taking the … Full story available on Benzinga.com
   Why Biohaven (BHVN) Might Surprise This Earnings Season  2020/05/04 12:47:00 Zacks Investment Research
Biohaven (BHVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   Biohaven Enters Into Agreement With Genpharm for Distribution of NURTEC™ ODT in the Middle East  2020/04/27 11:30:00 PR Newswire
NEW HAVEN, Conn., April 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT (rimegepant) in the Middle East…
   Biohaven Pharmaceutical's Migraine Drug To Be Promoted by Khloe Kardashian  2020/07/16 09:45:38 Benzinga
Biohaven Pharmaceutical Holding Co. Ltd.'s (NYSE: BHVN ) "Nurtec ODT" drug will be promoted by media personality Khloe Kardashian, the company announced Wednesday. What Happened Kardashian is joining the New Haven, Connecticut-based company's "Take Back Today" campaign, aimed at promoting the recently-launched orally dissolving tablet for people suffering from migraines. The 36-year old, of the "Keeping Up with the Kardashians" fame, said in a statement that she has been taking the … Full story available on Benzinga.com
   Why Biohaven (BHVN) Might Surprise This Earnings Season  2020/05/04 12:47:00 Zacks Investment Research
Biohaven (BHVN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
   Biohaven Enters Into Agreement With Genpharm for Distribution of NURTEC™ ODT in the Middle East  2020/04/27 11:30:00 PR Newswire
NEW HAVEN, Conn., April 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Genpharm Services, a leading partner for innovative pharmaceuticals in Dubai, announced today an agreement to distribute NURTEC™ ODT (rimegepant) in the Middle East…
   Biohaven Changing 2020 Annual Meeting Of Shareholders To Virtual-Only Meeting Format Due To COVID-19  2020/04/16 21:42:00 PR Newswire
NEW HAVEN, Conn., April 16, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that its Board of Directors has decided to hold the company's 2020 Annual Meeting of Shareholders on Thursday, April 30, 2020 at 10:00 a.m. Atlantic Time (9:00 a.m….
   Biohaven Enters Into Partnership With Medison Pharma To Distribute NURTEC™ ODT In Israel  2020/04/16 11:30:00 PR Newswire
NEW HAVEN, Conn., April 16, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Medison Pharma, Israel's leading partner for innovative pharmaceuticals, announced today an agreement to distribute NURTEC™ ODT (rimegepant) in Israel. NURTEC ODT is…

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 BIOHAVN PHRMCTCL BHVN )

 twitter  (公式ツイッターやCEOツイッターなど)